NCT04650035

Brief Summary

Background: COVID-19 is an acute respiratory pandemic with no available effective antiviral treatment or widely available effective vaccine. Surgical practice has faced widespread problems due to the pandemic including viral transmission risk and cross-infection, staffing problems, prioritizations of surgical procedures and lack of beds due to occupancy of hospitals and ICU beds with COVID-19 patients; Methods: A survey was conducted between October 31 to November 4, 2020, through google forms. The questionnaire involved 16 questions sent to consultants and specialists of all general and special surgical specialties and subspecialties in Jordan;

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2020

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2020

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 2, 2020

Completed
Last Updated

December 3, 2020

Status Verified

December 1, 2020

Enrollment Period

3 days

First QC Date

December 1, 2020

Last Update Submit

December 1, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of surgical operations performed whether elective or emergency

    difference between the monthly rate of operations during 2019 and the month of October 2020.

    October 2020

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan

You may qualify if:

  • Consultants and specialists of all general and special surgical specialties and subspecialties in Jordan

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yarmouk University

Irbid, 21163, Jordan

Location

Related Publications (5)

  • Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.

    PMID: 32169119BACKGROUND
  • Lam S, Lombardi A, Ouanounou A. COVID-19: A review of the proposed pharmacological treatments. Eur J Pharmacol. 2020 Nov 5;886:173451. doi: 10.1016/j.ejphar.2020.173451. Epub 2020 Aug 6.

    PMID: 32768505BACKGROUND
  • Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, O'Neill N, Iosifidis C, Griffin M, Mathew G, Agha R. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 1. Int J Surg. 2020 Jul;79:168-179. doi: 10.1016/j.ijsu.2020.05.022. Epub 2020 May 12.

    PMID: 32407799BACKGROUND
  • Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni L, Scandroglio I, Marini P, Zago M, De Paolis P, Forfori F, Agresta F, Puzziello A, D'Ugo D, Bignami E, Bellini V, Vitali P, Petrini F, Pifferi B, Corradi F, Tarasconi A, Pattonieri V, Bonati E, Tritapepe L, Agnoletti V, Corbella D, Sartelli M, Catena F. Surgery in COVID-19 patients: operational directives. World J Emerg Surg. 2020 Apr 7;15(1):25. doi: 10.1186/s13017-020-00307-2.

    PMID: 32264898BACKGROUND
  • Russell FM, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccin Immunother. 2021 May 4;17(5):1317-1321. doi: 10.1080/21645515.2020.1827882. Epub 2020 Nov 3.

    PMID: 33141000BACKGROUND

Related Links

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Raed M Ennab

    Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 1, 2020

First Posted

December 2, 2020

Study Start

November 1, 2020

Primary Completion

November 4, 2020

Study Completion

November 10, 2020

Last Updated

December 3, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations